Your browser doesn't support javascript.
loading
No impact of CD34+ cell dose on outcome among children undergoing autologous hematopoietic stem cell transplant for high-risk neuroblastoma.
Knight, Tristan E; Ahn, Kwang Woo; Hebert, Kyle M; Atshan, Rasha; Wall, Donna A; Chiengthong, Kanhatai; Lund, Troy C; Prestidge, Tim; Rangarajan, Hemalatha G; Dvorak, Christopher C; Auletta, Jeffery J; Kent, Michael; Hashem, Hasan; Talano, Julie-An; Rotz, Seth J; Fraint, Ellen; Myers, Kasiani C; Leung, Wing; Sharma, Akshay; Bhatt, Neel S; Driscoll, Timothy A; Yu, Lolie C; Schultz, Kirk R; Qayed, Muna; Broglie, Larisa; Eapen, Mary; Yanik, Gregory A.
Afiliación
  • Knight TE; Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, WA, USA.
  • Ahn KW; Division of Hematology and Oncology, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.
  • Hebert KM; Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Atshan R; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Wall DA; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Chiengthong K; CIBMTR® (Center for International Blood and Marrow Transplant Research), Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Lund TC; Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
  • Prestidge T; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.
  • Rangarajan HG; King Chulalongkorn Memorial Hospital, Thai Red Cross Society, Bangkok, Thailand.
  • Dvorak CC; Division of Pediatric Blood and Marrow Transplantation & Cellular Therapy, University of Minnesota, Minneapolis, MN, USA.
  • Auletta JJ; Blood and Cancer Centre, Starship Children's Hospital, Auckland, New Zealand.
  • Kent M; Department of Pediatric Hematology, Oncology, Blood and Marrow Transplantation, Nationwide Children's Hospital, Columbus, OH, USA.
  • Hashem H; Division of Pediatric Allergy, Immunology & Bone Marrow Transplantation, Benioff Children's Hospital, University of California San Francisco, San Francisco, CA, USA.
  • Talano JA; CIBMTR® (Center for International Blood and Marrow Transplant Research), National Marrow Donor Program/Be The Match, Minneapolis, MN, USA.
  • Rotz SJ; Hematology/Oncology/BMT and Infectious Diseases, Nationwide Children's Hospital, Columbus, OH, USA.
  • Fraint E; Atrium Health Levine Children's, Charlotte, NC, USA.
  • Myers KC; Division of Pediatric Hematology/Oncology and Bone Marrow Transplantation, King Hussein Cancer Center, Amman, Jordan.
  • Leung W; Department of Pediatric Hematology Oncology, Medical College of Wisconsin, Milwaukee, WI, USA.
  • Sharma A; Department of Pediatric Hematology, Oncology, and Blood and Marrow Transplantation, Cleveland Clinic, Cleveland, OH, USA.
  • Bhatt NS; Division of Pediatric Hematology, Oncology, and Cellular Therapy, The Children's Hospital at Montefiore, Bronx, NY, USA.
  • Driscoll TA; Department of Pediatrics, University of Cincinnati College of Medicine, Division of Bone Marrow Transplantation and Immune Deficiency, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Yu LC; Duke-NUS Medical School, Singapore, Singapore.
  • Schultz KR; Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA.
  • Qayed M; Division of Hematology and Oncology, Department of Pediatrics, University of Washington School of Medicine, Seattle, WA, USA.
  • Broglie L; Clinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.
  • Eapen M; Duke University Pediatric Transplantation and Cellular Therapy, Durham, NC, USA.
  • Yanik GA; Division of Hematology/Oncology & HSCT, The Center for Cancer and Blood Disorders, Children's Hospital, Louisiana State University Medical Center, New Orleans, LA, USA.
Bone Marrow Transplant ; 58(12): 1390-1393, 2023 12.
Article en En | MEDLINE | ID: mdl-37666957
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Trasplante de Células Madre de Sangre Periférica / Neuroblastoma Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante de Células Madre Hematopoyéticas / Trasplante de Células Madre de Sangre Periférica / Neuroblastoma Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Child / Humans Idioma: En Revista: Bone Marrow Transplant Asunto de la revista: TRANSPLANTE Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos